Phosphodiesterases in heart and vessels-From Physiology to Diseases
Phosphodiesterases (PDEs) are a superfamily of enzymes that hydrolyze cyclic nucleotides,
including cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate …
including cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate …
Loss of transforming growth factor beta signaling in aortic smooth muscle cells causes endothelial dysfunction and aortic hypercontractility
J Zhu, S Angelov, I Alp Yildirim, H Wei… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Humans and mice with loss-of-function variants of genes in the TGF-β
(transforming growth factor beta) signaling pathway develop aortic aneurysms. These …
(transforming growth factor beta) signaling pathway develop aortic aneurysms. These …
Development and Application of an Optogenetic Manipulation System to Suppress Actomyosin Activity in Ciona Epidermis
J Qiao, H Peng, B Dong - International Journal of Molecular Sciences, 2023 - mdpi.com
Studying the generation of biomechanical force and how this force drives cell and tissue
morphogenesis is challenging for understanding the mechanical mechanisms underlying …
morphogenesis is challenging for understanding the mechanical mechanisms underlying …
Myosin light chain phosphatase catalytic subunit dephosphorylates cardiac myosin via mechanisms dependent and independent of the MYPT regulatory subunits
Cardiac muscle myosin regulatory light chain (RLC) is constitutively phosphorylated at∼ 0.4
mol phosphate/mol RLC in normal hearts, and phosphorylation is maintained by balanced …
mol phosphate/mol RLC in normal hearts, and phosphorylation is maintained by balanced …
Complex functionality of protein phosphatase 1 isoforms in the heart
R Liu - Cellular Signalling, 2021 - Elsevier
Abstract Protein phosphatase 1 (PP1) is a key regulator of cardiac function through
dephosphorylating serine/threonine residues within target proteins to oppose the function of …
dephosphorylating serine/threonine residues within target proteins to oppose the function of …
The MYPT2-regulated striated muscle-specific myosin light chain phosphatase limits cardiac myosin phosphorylation in vivo
E Lee, H May, K Kazmierczak, J Liang… - Journal of Biological …, 2024 - ASBMB
The physiological importance of cardiac myosin regulatory light chain (RLC)
phosphorylation by its dedicated cardiac myosin light chain kinase has been established in …
phosphorylation by its dedicated cardiac myosin light chain kinase has been established in …
Tissue-specific expression of myosin phosphatase subunits and isoforms in smooth muscle of mice and humans
Alternative splicing of exon24 (E24) of myosin phosphatase targeting subunit 1 (Mypt1) by
setting sensitivity to nitric oxide (NO)/cGMP-mediated relaxation is a key determinant of …
setting sensitivity to nitric oxide (NO)/cGMP-mediated relaxation is a key determinant of …
Characterisation of P2 receptors that modulate vascular tone in pulmonary arteries
MO Dales - 2022 - stax.strath.ac.uk
Purinergic P2Y receptors are a family of eight G protein-coupled receptors (P2Y1, 2, 4, 6, 11,
12, 13, 14) that are activated by nucleotides to elicit both vasoconstriction and vasodilation …
12, 13, 14) that are activated by nucleotides to elicit both vasoconstriction and vasodilation …
The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function
The molecular mechanisms of regulation of myometrial contractility, and, hence, the
mechanisms of regulation of the onset of labor and delivery during pregnancy have been an …
mechanisms of regulation of the onset of labor and delivery during pregnancy have been an …
Exploring Myosin RLC Phosphorylation as a Potential Novel Therapeutic Target for Hypertrophic Cardiomyopathy
S Yadav - 2019 - search.proquest.com
Background: Hypertrophic Cardiomyopathy (HCM) is one of the most prevalent heart
diseases characterized by ventricular and septal hypertrophy, myocardial fibrosis and …
diseases characterized by ventricular and septal hypertrophy, myocardial fibrosis and …